We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
FCDO travel advice for Jamaica. Includes safety and security, insurance, entry requirements and legal differences.
Details of the Yellow Card scheme, which is the system for recording adverse incidents with medicines and medical devices in the UK.
What packaged goods are, how they are labelled, units of measurements used and compliance with weights and measures regulation.
This guidance describes case definitions to inform testing and reporting of suspected mpox cases.
Invasive alien plant species have negative impacts on biodiversity, ecosystem services and human well-being
A patient alert card is being introduced for men taking finasteride to help raise awareness of the risk of psychiatric side effects and sexual dysfunction, including the potential for sexual dysfunction to persist after treatment has stopped. Healthcare professionals are...
Information about when you need to submit substantial amendments to a clinical trial including changes to the trial sponsor or legal representative, Investigational medicinal product certification and importation.
FCDO travel advice for Trinidad and Tobago. Includes safety and security, insurance, entry requirements and legal differences.
Guidance on Conditional Marketing Authorisations, exceptional circumstances Marketing Authorisations and national scientific advice
Advice for medical professionals to follow when assessing drivers with neurological disorders.
For reporting mandatory surveillance of Escherichia coli bacteraemia, Klebsiella species and Pseudomonas aeruginosa to Public Health England.
Explains changes to drug driving law and the guidance available for healthcare professionals and users of prescription medicine.
Form ST1: Statement of truth in support of an application for registration based upon adverse possession.
Advice for medical professionals to follow when assessing drivers with drug or alcohol misuse or dependence.
Information to support your recovery after COVID-19.
Find out if a claim of ownership by adverse possession can be made on common land and town or village greens, what effect it will have on the land and whether a claim can be opposed.
These reports explain our assessment of the scientific evidence used to lead to regulatory decisions on the safety of medicines or medicines classes.
Guidance on what BNG is and how it affects land managers, developers and local planning authorities.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. We’ll send you a link to a feedback form. It will take only 2 minutes to fill in. Don’t worry we won’t send you spam or share your email address with anyone.